Latest California Healthline Stories
Health Law’s 10 Essential Benefits: A Look At What’s At Risk In GOP Overhaul
The woman set to run the federal Centers for Medicare & Medicaid Services told senators last week that maternity coverage should be optional in individual and small group plans. But other services could also be left on the cutting room floor.
A Safety-Net Medical Center Wrestles With What ‘Repeal’ Might Mean
San Mateo Medical Center is among hundreds of safety-net hospitals in California and across the country that stand to lose big if the federal government slashes support for Medicaid and insurance exchanges.
A New Diagnosis: ‘Post-Election Stress Disorder’
Trump opponents — and even some supporters — say the election and tumultuous early days of the new administration have left them anxious, angry and afraid of Facebook.
Docs In Northwest Tweak Aid-In-Dying Drugs To Prevent Prolonged Deaths
Some terminal patients, typically high-dose opioid users, who choose to end their lives have taken many hours, even days, to die.
Single-Payer Health Care Bill Introduced In California Senate
The legislation is only a first step, declaring the “intent” of the state Senate without specifics or a timetable.
Veteran Teaches Therapists How To Talk About Gun Safety When Suicide’s A Risk
Most veterans who commit suicide do so with a gun, but most therapists don’t understand gun culture. A veteran who has struggled with depression himself now helps bridge that gap by educating mental health professionals.
Individual Insurance Primer: Long-Troubled Market At Center Of Drive For Repeal
People who do not get insurance through their job or the government have long battled a difficult market.
Some Immigrants, Fearful Of Political Climate, Shy Away From Medi-Cal
Some foreign-born California residents fear they could be penalized for using Medi-Cal and other social benefits. Others, in families of mixed-immigration status, worry about jeopardizing their loved ones’ chances of becoming green-card holders or citizens.
5 Reasons Why An $89,000 Drug Has Congress Fuming
A drug from Marathon Pharmaceuticals has ignited a firestorm on Capitol Hill and beyond. What makes it different than the $750,000 drug that came before it?
An Alzheimer’s ‘Tsunami’ Threatens Latinos
The number of U.S. Latinos with the memory-robbing disease is expected to rise more than eightfold by 2060, to 3.5 million, according to a recent report — putting a strain on families and health care resources.